Skip to content

Return on equity at other companies

Humana logo
HumanaHUM
18.2%+0.9pp
CVS Health logo
CVS HealthCVS
3.8%-3.2pp
UnitedHealth Group logo
UnitedHealth GroupUNH
11.8%-11.1pp
Astrana Health logo
Astrana HealthASTH
3.9%
Agilon Health logo
Agilon HealthAGL
-104%-291pp
Clover Health Investments logo
Clover Health InvestmentsCLOV
-16.9%-170pp

Other financials

Income statement

See full
Revenue$251.9M+15.5%
Operating income-$29.1M-186%
Net income-$29.5M-159%
EPS (diluted)-$0.22-175%

Balance sheet

See full
Cash & equivalents$95.5M+58.0%
Total debt$93.8M-11.0%
Total equity$229.0M-3.8%
Total assets$547.4M+2.0%

Cash flow

See full
Operating cash flow$18.1M-26.3%
CapEx$3.6M+24.3%
Free cash flow$14.5M-33.1%

Valuation

See full
Market cap$1.31B+170%
Enterprise value$1.31B+143%
P/S1.4×+0.8×

Profitability

See full
Operating margin-1%-0.4pp
Net margin-1.2%-0.5pp
FCF margin4.5%+2.6pp

Returns & leverage

See full
Debt / equity0.4×0.0×
Current ratio+0.3×

Where this comes from

Calculated from InnovAge Holdings, Inc.’s reported figures.

Based on trailing twelve months.

The official record: InnovAge Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about InnovAge Holdings, Inc.'s return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is InnovAge Holdings, Inc.'s return on equity?
InnovAge Holdings, Inc. (INNV) reported return on equity of -5% in Q1 2026.
How has InnovAge Holdings, Inc.'s return on equity changed year-over-year?
InnovAge Holdings, Inc.'s return on equity increased by 58.7% year-over-year, from -12% to -5%.
What is the long-term trend for InnovAge Holdings, Inc.'s return on equity?
Over 3 years (2022 to 2025), InnovAge Holdings, Inc.'s return on equity has grown at a 83.2% compound annual growth rate (CAGR), from -2% to -12%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.